Nu-Med Plus (NUMD) Share-based Compensation Growth (1y) (2013 - 2021)
Nu-Med Plus (NUMD) Share-based Compensation Growth (1y) (2013 - 2021) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.47 Bn | 176.17 Bn | 6.27 Bn | 9.69% |
| 2 | Stryker | 128.89 Bn | 126.01 Bn | 3.81 Bn | 37.62% |
| 3 | Medtronic | 108.71 Bn | 99.49 Bn | 6.41 Bn | 6.74% |
| 4 | Boston Scientific | 68.50 Bn | 67.05 Bn | 3.61 Bn | 12.16% |
| 5 | Edwards Lifesciences | 48.59 Bn | 44.92 Bn | 1.29 Bn | 12.94% |
| 6 | Dexcom | 28.40 Bn | 27.29 Bn | 750.30 Mn | - |
| 7 | GE HealthCare Technologies | 28.34 Bn | 26.06 Bn | 1.98 Bn | 59.09% |
| 8 | Smith & Nephew | 26.93 Bn | 26.35 Bn | - | - |
| 9 | Koninklijke Philips | 25.50 Bn | 22.37 Bn | 2.07 Bn | -30.44% |
| 10 | Nu-Med Plus | 1.67 Mn | 1.67 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 21.13% |
| Mar 31, 2021 | 1,348.63% |
| Dec 31, 2020 | -3,512.26% |
| Sep 30, 2020 | 75.00% |
| Jun 30, 2020 | 1,122.30% |
| Mar 31, 2020 | 0.00% |
| Dec 31, 2019 | 106.30% |
| Sep 30, 2019 | -92.18% |
| Jun 30, 2019 | 0.00% |
| Mar 31, 2019 | 0.00% |
| Dec 31, 2018 | -1,138.53% |
| Sep 30, 2018 | 2,461.22% |
| Dec 31, 2017 | -111.35% |
| Sep 30, 2017 | 111.35% |
| Dec 31, 2016 | 141.32% |
| Sep 30, 2016 | -141.32% |
| Dec 31, 2015 | -208.44% |
| Sep 30, 2015 | 166.97% |
| Mar 31, 2015 | -88.71% |
| Sep 30, 2014 | 342.91% |